S8 - Doenças da Suprarrenal (Hiperaldosteronismo, Feocromocitoma) Flashcards

1
Q

Adrenal Incidentalomas?

A

Adrenal mass (>1 cm), which is discovered incidentally on an imaging examination performed for unrelated reasons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Assessment of the risk of malignancy?

A

Establish if an adrenal mass is benign or malignant at the time of initial detection.
Adrenal incidentalomas undergo an imaging procedure to determine if the mass is homogeneous and lipid-rich and therefore benign (noncontrast CT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What non-contrast CT characteristics are consistent with a benign adrenal mass?

A

Homogeneous and smaller than 4 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Size and relation with risk?

A

Size remains an important predictor of the risk of adrenal cortical cancer and needs to be taken into account during evaluation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If the adrenal mass is indeterminate on non-contrast CT and the results of the hormonal work-up do not indicate significant hormone excess?

A

Immediate additional imaging with another modality
Interval imaging in 6– 12 months (non-contrast CT or MRI)
Surgery without further delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Biopsy?

A

Recommend against the use of an adrenal biopsy in the diagnostic work-up of patients with adrenal masses unless there is a history of extra-adrenal malignancy and additional criteria are fulfilled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Assessment for hormone excess?

A

All patients with adrenal incidentalomas undergo a 1 mg overnight DST to exclude cortisol excess
Serum cortisol levels post dexamethasone (≤1.8 μg/dL) as a diagnostic criterion for the exclusion of autonomous cortisol secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1 mg overnight DST results?

A

Serum cortisol levels post dexamethasone (≤1.8 μg/dL) as a diagnostic criterion for the exclusion of autonomous cortisol secretion.
Cortisol levels of 1.9–5.0 μg/dL should be considered as evidence of ‘possible autonomous cortisol secretion’
Cortisol levels post dexamethasone >5.0 μg/dL) should be taken as evidence of ‘autonomous cortisol secretion’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Screening de comorbilidades?

A

Screening patients with ‘possible autonomous cortisol secretion’ or ‘autonomous cortisol secretion’ for hypertension and type 2 Diabetes Mellitus, and asymptomatic vertebral fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should be considered in all patients considered for surgery?

A

ACTH-independency of cortisol excess should be confirmed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The recommended way to exclude pheochromocytoma?

A

Measurement of plasma-free metanephrines or

urinary fractionated metanephrines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patients with concomitant hypertension or

unexplained hypokalemia?

A

Use of the aldosterone/renin ratio to exclude primary

aldosteronism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients with clinical or imaging features suggestive of adrenocortical carcinoma?

A

Measurement of sex hormones and steroid precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metastases to the adrenal glands?

A

Primary tumors of the lung, breast, kidney, and gastrointestinal tract and melanoma or lymphoma
Typically bilateral and large (>3 cm)
History of malignant disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risk of pheochromocytoma in the autopsy?

A

Hypertensive crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosis of Glucocorticoids Hypersecretion?

A

1mg overnight dexamethasone test
Urine 24h cortisol
Salivary cortisol

17
Q

Cushing Syndrome ACTH dependency?

A

Plasma ACTH

18
Q

Efeitos estrogénios em niveis homronais?

A

Aumentam proteínas de transporte o que aumenta frações hormonais na corrente sanguínea

19
Q

Prova de frenação com dose baixa? Dose alta?

A

Síndrome de Cushing. Hipofisária ou Primária

20
Q

Case detection of Hyperaldosteronism?

A

Sustained BP above 150/100 mm Hg
BP 140/90 resistant to 3 conventional antihypertensive drugs
Controlled BP (140/90 mm Hg) on four or more antihypertensive drugs
Hypertension (HT) and spontaneous or diuretic-induced hypokalemia
HT and adrenal incidentaloma
HT and sleep apnea
HT and a family history of early-onset HT
HT 1st degree relatives of patients with PA

21
Q

Detect possible cases of PA?

A

Plasma aldosterone/renin ratio (ARR)

22
Q

Algorithm for the detection, confirmation, subtype testing, and treatment of PA?

A

ARR, ARR (confirmativo), CT adrenal, MR Antagonist or Laparocsopic Adrenalectomy

23
Q

Spontaneous hypokalemia?

A

concentration (PAC)> 20 ng/dL, we suggest that there may is no need for further confirmatory testing.

24
Q

PA Confirmatory Tests?

A

Oral sodium loading test
Sodium Infusion Test
Fludrocortisone Suppression Test
Captopril Challenge Test

25
Q

Problemas com TAC/RM?

A
Falsos positivos (1/3 são incidentalomas)
Falsos negativos (1/3 dos adenomas não são visualisáveis devido às pequenas dimensões)
26
Q

Cateterismo dos seios petrosos inferiores?

A

Diagnóstico entre ectópicos e hipofisários

Ratio entre central e perfiférico

27
Q

Cateterismo das veias suprarrenais?

A

Blood from both adrenal veins and a peripheral vein (labeled peripheral) is taken and assayed for aldosterone and cortisol concentrations

28
Q

Avaliação bioquímica para diagnóstico de Feocromocitomas e Paragangliomas?

A

Teste inicial para FeoPGL seja a determinação das metanefrinas plasmáticas e as metanefrinas fraccionadas urinárias (colheita do doente na posição supina)

29
Q

Estudos de Imagem de Feocromocitomas e Paragangliomas?

A

Iniciados logo que haja evidência bioquímica clara de um FeoPGL. TC em vez da RM como modalidade de imagem de escolha.
Uso de cintigrafia MIBG como modalidade functional em doentes FeoPGL metastáticos.
18F-FDGPET/CT é a modalidade preferencial sobre a cintigrafia com MIBG.

30
Q

Testes Genéticos de Feocromocitomas e Paragangliomas?

A

Paraganglioma sejam testados para mutações da succinato desidrogenase (SDH) e que doentes com doença metastática a sejam testados para mutações SDHB.

31
Q

Tratamento Médico Perioperatório de Feocromocitomas e Paragangliomas?

A

Doentes com FeoPGL funcionantes devem ser submetidos a bloqueio pré-operatório.
Tratamento médico durante 7 a 14 dias para permitir adequada normalização da PA e frequência cardíaca.
Doseamento de metanefrinas plasmáticas e urinárias no seguimento para diagnóstico persistência da doença.

32
Q

Cirurgia de Feocromocitomas e Paragangliomas??

A

Suprarrenalectomia minimamente invasiva

33
Q

Prognóstico de uma lesão suprarrenal?

A

Variável com o diagnóstico.
O prognóstico é bastante favorável caso a cirurgia seja bem sucedida.
Mau no carcinoma suprarrenal.